215 related articles for article (PubMed ID: 31534502)
1. Enhanced cancer therapy through synergetic photodynamic/immune checkpoint blockade mediated by a liposomal conjugate comprised of porphyrin and IDO inhibitor.
Huang Z; Wei G; Zeng Z; Huang Y; Huang L; Shen Y; Sun X; Xu C; Zhao C
Theranostics; 2019; 9(19):5542-5557. PubMed ID: 31534502
[TBL] [Abstract][Full Text] [Related]
2. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
[TBL] [Abstract][Full Text] [Related]
3. Nanoconjugates to enhance PDT-mediated cancer immunotherapy by targeting the indoleamine-2,3-dioxygenase pathway.
Yang X; Zhang W; Jiang W; Kumar A; Zhou S; Cao Z; Zhan S; Yang W; Liu R; Teng Y; Xie J
J Nanobiotechnology; 2021 Jun; 19(1):182. PubMed ID: 34127005
[TBL] [Abstract][Full Text] [Related]
4. Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway.
Lu J; Liu X; Liao YP; Wang X; Ahmed A; Jiang W; Ji Y; Meng H; Nel AE
ACS Nano; 2018 Nov; 12(11):11041-11061. PubMed ID: 30481959
[TBL] [Abstract][Full Text] [Related]
5. Development of a functionalized UV-emitting nanocomposite for the treatment of cancer using indirect photodynamic therapy.
Sengar P; Juárez P; Verdugo-Meza A; Arellano DL; Jain A; Chauhan K; Hirata GA; Fournier PGJ
J Nanobiotechnology; 2018 Feb; 16(1):19. PubMed ID: 29482561
[TBL] [Abstract][Full Text] [Related]
6. Comparison study of different indoleamine-2,3 dioxygenase inhibitors from the perspective of pharmacodynamic effects.
Jiang X; Li X; Zheng S; Du G; Ma J; Zhang L; Wang H; Tian J
Int J Immunopathol Pharmacol; 2020; 34():2058738420950584. PubMed ID: 32962460
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia alleviation-triggered enhanced photodynamic therapy in combination with IDO inhibitor for preferable cancer therapy.
Xing L; Gong JH; Wang Y; Zhu Y; Huang ZJ; Zhao J; Li F; Wang JH; Wen H; Jiang HL
Biomaterials; 2019 Jun; 206():170-182. PubMed ID: 30939409
[TBL] [Abstract][Full Text] [Related]
8. Investigation of PPIX-Lipo-MnO
Chudal L; Pandey NK; Phan J; Johnson O; Li X; Chen W
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109979. PubMed ID: 31500001
[TBL] [Abstract][Full Text] [Related]
9. The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
Fukuhara H; Inoue K; Kurabayashi A; Furihata M; Fujita H; Utsumi K; Sasaki J; Shuin T
Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):399-409. PubMed ID: 24284092
[TBL] [Abstract][Full Text] [Related]
10. The synthesis of 64Cu-chelated porphyrin photosensitizers and their tumor-targeting peptide conjugates for the evaluation of target cell uptake and PET image-based pharmacokinetics of targeted photodynamic therapy agents.
Mukai H; Wada Y; Watanabe Y
Ann Nucl Med; 2013 Aug; 27(7):625-39. PubMed ID: 23605059
[TBL] [Abstract][Full Text] [Related]
11. Combinatorial antitumor effects of indoleamine 2,3-dioxygenase inhibitor NLG919 and paclitaxel in a murine B16-F10 melanoma model.
Meng X; Du G; Ye L; Sun S; Liu Q; Wang H; Wang W; Wu Z; Tian J
Int J Immunopathol Pharmacol; 2017 Sep; 30(3):215-226. PubMed ID: 28604143
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence detection and depletion of T47D breast cancer cells from human mononuclear cell-enriched blood preparations by photodynamic treatment: Basic in vitro experiments towards the removal of circulating tumor cells.
Ziegler VG; Knaup J; Stahl D; Krammer B; Plaetzer K
Lasers Surg Med; 2011 Sep; 43(7):548-56. PubMed ID: 22057482
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the in vitro and in vivo effects of photodynamic therapy on prostate cancer by using new photosensitizers, protoporphyrin IX-polyamine derivatives.
Fidanzi-Dugas C; Liagre B; Chemin G; Perraud A; Carrion C; Couquet CY; Granet R; Sol V; Léger DY
Biochim Biophys Acta Gen Subj; 2017 Jul; 1861(7):1676-1690. PubMed ID: 28188858
[TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro characterisation of a protoporphyrin IX-cyclic RGD peptide conjugate for use in photodynamic therapy.
Conway CL; Walker I; Bell A; Roberts DJ; Brown SB; Vernon DI
Photochem Photobiol Sci; 2008 Mar; 7(3):290-8. PubMed ID: 18389145
[TBL] [Abstract][Full Text] [Related]
15. A phthalocyanine-based photosensitizer for effectively combating triple negative breast cancer with enhanced photodynamic anticancer activity and immune response.
Huang K; Yan M; Zhang H; Xue J; Chen J
Eur J Med Chem; 2022 Nov; 241():114644. PubMed ID: 35939997
[TBL] [Abstract][Full Text] [Related]
16. Cascade Immune Activation of Self-Delivery Biomedicine for Photodynamic Immunotherapy Against Metastatic Tumor.
Zheng RR; Zhao LP; Yang N; Chen ZX; Kong RJ; Huang CY; Rao XN; Chen X; Cheng H; Li SY
Small; 2023 Jan; 19(3):e2205694. PubMed ID: 36366925
[TBL] [Abstract][Full Text] [Related]
17. Tumor Cell-Responsive Photodynamic Immunoagent for Immunogenicity-Enhanced Orthotopic and Remote Tumor Therapy.
Chen Y; Xiong T; Zhao X; Du J; Sun W; Fan J; Peng X
Adv Healthc Mater; 2023 Feb; 12(5):e2202085. PubMed ID: 36377488
[TBL] [Abstract][Full Text] [Related]
18. Light-responsive hyaluronic acid nanomicelles co-loaded with an IDO inhibitor focus targeted photoimmunotherapy against "immune cold" cancer.
Wu C; Xu J; Xie Z; Huang H; Li N; Wei X; Li T; Yang H; Li S; Qin X; Liu Y
Biomater Sci; 2021 Nov; 9(23):8019-8031. PubMed ID: 34718362
[TBL] [Abstract][Full Text] [Related]
19. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
[TBL] [Abstract][Full Text] [Related]
20. ROS-responsive liposomes with NIR light-triggered doxorubicin release for combinatorial therapy of breast cancer.
Yi H; Lu W; Liu F; Zhang G; Xie F; Liu W; Wang L; Zhou W; Cheng Z
J Nanobiotechnology; 2021 May; 19(1):134. PubMed ID: 33975609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
